Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
200 Northcote Road , England, E17 7DH, GB
Kane will advance strategic priorities and advance Solrikitug, its lead asset, in Phase II trials and prepare for Phase III.
By: Rachel Klemovitch
Aim to deliver an advanced, fully tested, fully automated robotically operated CGT manufacturing platform to the market.
By: Charlie Sternberg
The antibody, ISB 2001, is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM).
Aligns with the company’s broader strategy to invest significantly across its global network.
The Phase 3 study evaluating quemliclustat plus chemotherapy as a first-line treatment for metastatic pancreatic cancer is expected to be fully enrolled by the end of this year.
Enables real-time data access, full traceability, and enhanced regulatory compliance.
Gala brings more than 30 years of experience across finance, strategy, corporate development, and commercialization.
Linda Jónsdóttir is a highly experienced international executive with a strong background in finance and corporate leadership.
Provides a singular solution to address degradation drivers for pharmaceutical drugs.
Kulkarni will lead the strategic direction and operations of ACG’s engineering division.
The collaboration aims to enable researchers to easily adapt workflows to their applications while improving efficiency and reproducibility.
Strengthens Ofichem’s integrated development offering, enabling it to offer broader, deeper support from early-phase development through to GMP production.
Dr. Barker is an experienced clinical immunologist with broad executive experience across both big pharma and biotech.
Dr. Richard Philipson has 25+ years of industry experience and a successful track record in drug development.
The addition of 62,000 square meters of new development in 2026 will more than double the total footprint of the site to 108,000 square meters.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
